Eupraxia Pharmaceuticals EPRX
NASDAQ EPRX
$8.06 +0.43 (+5.64%)
At close: Nov 11, 2026 · 4:00 PM EST

Eupraxia Pharmaceuticals (EPRX) Total Debt (2022 - 2024)

Updated

Eupraxia Pharmaceuticals' Total Debt was -$355,582 in Q4 2024, compared with $10.46 million a year earlier.

Analysis

Eupraxia Pharmaceuticals (EPRX) Total Debt (2022 - 2024) Analysis & Trends

From Q4 2022 onward, Eupraxia Pharmaceuticals has reported Total Debt for 5 quarters.

  • In earlier years, Total Debt was $10.46 million in FY2023 and $221,545 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 49.50 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 44.65 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 80.90 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 53.78 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -6.68 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 54.01 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 26.23 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 62.67 Bn
10 Eupraxia Pharmaceuticals 304.87 Mn -174.66 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -355,582.00
Jun 30, 2024 21,209.00
Mar 31, 2024 42,112.00
Dec 31, 2023 10.46 Mn
Dec 31, 2022 221,545.00
API Access

Eupraxia Pharmaceuticals Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=EPRX&period=max&api_key=YOUR_API_KEY